| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e87f29e0db9416800cab4f60f6c468 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 |
| filingDate |
2007-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a04fbf0b153174865b41bd129a29e5c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0be146b556bdbbc29691a975f391eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eef97df399e3ab7ce9d7df6079786f84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dec208e8bc8b1483c2dedca8c4b8ebc |
| publicationDate |
2009-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090057440-A |
| titleOfInvention |
Solid pharmaceutical composition of lamosetrone stable to light |
| abstract |
The present invention provides a lamosetrone formulation that is stable under light irradiation. The solid pharmaceutical composition of the present invention can provide a stable formulation by incorporating a compound that absorbs a specific wavelength into an unstable lamosetrone or a pharmaceutically acceptable salt thereof mainly under light irradiation. In particular, it is useful as a technique which can be applied to the low content formulation of lamosetron or its pharmaceutically acceptable salt, or an orally disintegrating tablet. Moreover, this invention relates to the stabilization method of the solid pharmaceutical composition of lamosetron or its pharmaceutically acceptable salt which mix | blends the compound of the characteristic which absorbs the light of a specific wavelength. |
| priorityDate |
2006-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |